BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8031472)

  • 1. Complement C3 deficiency: human, animal, and experimental models.
    Singer L; Colten HR; Wetsel RA
    Pathobiology; 1994; 62(1):14-28. PubMed ID: 8031472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An inherited deficiency of the third component of complement, C3, in guinea pigs.
    Burger R; Gordon J; Stevenson G; Ramadori G; Zanker B; Hadding U; Bitter-Suermann D
    Eur J Immunol; 1986 Jan; 16(1):7-11. PubMed ID: 3512275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary deficiency of C3 in animals and humans.
    Botto M; Walport MJ
    Int Rev Immunol; 1993; 10(1):37-50. PubMed ID: 8340676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of the third component of canine complement (C3) and identification of the mutation responsible for hereditary canine C3 deficiency.
    Ameratunga R; Winkelstein JA; Brody L; Binns M; Cork LC; Colombani P; Valle D
    J Immunol; 1998 Mar; 160(6):2824-30. PubMed ID: 9510185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis of an inherited deficiency of the third component of complement in Brittany spaniel dogs.
    Johnson JP; McLean RH; Cork LC; Winkelstein JA
    Am J Med Genet; 1986 Nov; 25(3):557-62. PubMed ID: 3789016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited human complement C3 deficiency. An amino acid substitution in the beta-chain (ASP549 to ASN) impairs C3 secretion.
    Singer L; Whitehead WT; Akama H; Katz Y; Fishelson Z; Wetsel RA
    J Biol Chem; 1994 Nov; 269(45):28494-9. PubMed ID: 7961791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H.
    S Reis E; Falcão DA; Isaac L
    Scand J Immunol; 2006 Mar; 63(3):155-68. PubMed ID: 16499568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of complement C3 deficiency in guinea pigs.
    Auerbach HS; Burger R; Dodds A; Colten HR
    J Clin Invest; 1990 Jul; 86(1):96-106. PubMed ID: 1973176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C3 deficiencies.
    Bitter-Suermann D; Burger R
    Curr Top Microbiol Immunol; 1990; 153():223-33. PubMed ID: 2404696
    [No Abstract]   [Full Text] [Related]  

  • 10. Inherited complement C3 deficiency: reduced C3 mRNA and protein levels in a Laotian kindred.
    Singer L; Van Hee ML; Lokki ML; Kramer J; Borzy MS; Wetsel RA
    Clin Immunol Immunopathol; 1996 Dec; 81(3):244-52. PubMed ID: 8938101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models for complement deficiencies.
    Frank MM
    J Clin Immunol; 1995 Nov; 15(6 Suppl):113S-121S. PubMed ID: 8613484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement deficiency promotes cutaneous wound healing in mice.
    Rafail S; Kourtzelis I; Foukas PG; Markiewski MM; DeAngelis RA; Guariento M; Ricklin D; Grice EA; Lambris JD
    J Immunol; 2015 Feb; 194(3):1285-91. PubMed ID: 25548229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted disruption of the murine gene coding for the third complement component (C3).
    Pekna M; Hietala MA; Rosklint T; Betsholtz C; Pekny M
    Scand J Immunol; 1998 Jan; 47(1):25-9. PubMed ID: 9467654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental allergic encephalomyelitis in cobra venom factor-treated and C4-deficient guinea pigs.
    Morariu MA; Dalmasso AP
    Ann Neurol; 1978 Nov; 4(5):427-30. PubMed ID: 83812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced death.
    Drake WP; Pokorney DR; Kopyta LP; Mardiney MR
    Biomedicine; 1976 May; 25(3):91-4. PubMed ID: 949521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first confirmed case with C3 deficiency caused by compound heterozygous mutations in the C3 gene; a new aspect of pathogenesis for C3 deficiency.
    Kida M; Fujioka H; Kosaka Y; Hayashi K; Sakiyama Y; Ariga T
    Blood Cells Mol Dis; 2008; 40(3):410-3. PubMed ID: 18201916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
    Cunnion KM; Benjamin DK; Hester CG; Frank MM
    J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple method to distinguish between primary and secondary C3 deficiencies.
    Pereira de Carvalho Florido M; Ferreira de Paula P; Isaac L
    Clin Diagn Lab Immunol; 2003 Mar; 10(2):216-20. PubMed ID: 12626445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role and mechanism of cobra venom factor-induced suppression of the humoral immune response in guinea pigs.
    Böttger EC; Hoffmann T; Metzger S; Hadding U; Bitter-Suermann D
    J Immunol; 1986 Aug; 137(4):1280-5. PubMed ID: 2942603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis.
    Alper CA; Colten HR; Gear JS; Rabson AR; Rosen FS
    J Clin Invest; 1976 Jan; 57(1):222-9. PubMed ID: 1107355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.